About Mba Pharmaceuticals Private Limited
Data last updated:
Mba Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2014PTC265441. Its GSTIN is 07AAJCM1075D1ZO (Delhi).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Jitender Kumar and Girish Kalra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4931 Plot No.68 Second Floor South Ansari Road Daryaganj, New Delhi, Delhi, India – 110002.
As per the financials filed for FY 2024, the company reported a revenue of ₹18.48 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹84,417 (net margin 0%) and EBITDA of ₹28.33 Lakh (EBITDA margin 1.5%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.
The company is associated with 1 brand: MBA Pharmaceuticals. As per MCA filings, the company has open charges of ₹1.2 Cr and satisfied charges of ₹1 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mbapharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address4931 Plot No.68 Second Floor South Ansari Road Daryaganj, New Delhi, Delhi, India – 110002
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mba Pharmaceuticals Private Limited
The main business activity of Mba Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mba Pharmaceuticals Private Limited FY 2025 filings available
Mba Pharmaceuticals Private Limited reported revenue of ₹18.48 Cr (down 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Mba Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 15% fall in the latest year. EBITDA fell 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mba Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹28.33 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹84,417 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mba Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mba Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mba Pharmaceuticals Private Limited
Mba Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shanpar Pharmachem Private Limited | ₹18.65 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Chennai, Tamil Nadu, India |
| Cornel Pharmaceuticals Private Limited | ₹18.56 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Ahmedabad, Gujarat, India |
| Acinta Pharmaceuticals Private Limited | ₹18.54 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Mannequin Pharmaceuticals Private Limited | ₹18.54 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Bhubaneswar, Odisha, India |
| Sal Corporation Private Limited | ₹18.49 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Ahmedabad, Gujarat, India |
| Mba Pharmaceuticals Private Limited this company | ₹18.48 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | New Delhi, Delhi, India |
| Globin Pharmaceuticals Private Limited | ₹18.48 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Palwal, Haryana, India |
| Sinsan Pharmaceuticals Private Limited | ₹18.47 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Pune, Maharashtra, India |
| Kale Impex Private Limited | ₹18.44 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Nagpur, Maharashtra, India |
| PMV Healthcare Private Limited | ₹18.43 Cr (FY 2017) | •••• | •••• | 20.0% | •••• | Hyderabad, Telangana, India |
| Astragen Laboratories Private Limited | ₹18.42 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Mba Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mba Pharmaceuticals Private Limited
Mba Pharmaceuticals Private Limited is audited by MOHIT OM JAIN AND COMPANY for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MOHIT OM JAIN AND COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mba Pharmaceuticals Private Limited
Mba Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitender Kumar | Director | 26 Feb 2014 | 12 Years 7 Months | Current |
| Girish Kalra | Director | 26 Feb 2014 | 12 Years 7 Months | Current |
Ownership and Shareholding of Mba Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mba Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Aug 2019 | Others | ₹1.2 Cr | Open |
| 26 Nov 2014 | Ing Vysya Bank Limited | ₹1 Cr | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Mba Pharmaceuticals Private Limited
Mba Pharmaceuticals Private Limited has 6 court cases on record: 5 filed by Mba Pharmaceuticals, 1 filed against it. All cases are disposed. Status as checked between 29 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 1 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Execution petition | Filed by the company against an individual | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Cadila Pharmaceutical Ltd | Disposed |
| District court, Central, Delhi | Civil suit | Filed by the company against an individual | Disposed |
| District court, Central, Delhi | Civil suit | Filed by the company against an individual | Disposed |
| District court, Central, Delhi | Civil suit | Filed by the company against an individual | Disposed |
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Mba Pharmaceuticals Private Limited
Mba Pharmaceuticals operates one associated brand: MBA Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, exporting, and wholesaling services based in India. | mbapharmaceuticals.com |
Employees and EPFO Compliance at Mba Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Mba Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mba Pharmaceuticals Private Limited
Mba Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Girish Kalra was appointed as Director on 26 Feb 2014.
Credit Ratings, Litigation & Regulatory Alerts for Mba Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mba Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mba Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mba Pharmaceuticals Private Limited
Mba Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCM1075D1ZO | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mba Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mba Pharmaceuticals Private Limited
Mba Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 February 2014 (12+ years old) and is registered under CIN U51397DL2014PTC265441.
Mba Pharmaceuticals reported revenue of ₹18.48 Cr for FY 2024 (down 15% YoY).
Mba Pharmaceuticals has 2 current directors:
- Jitender Kumar - Director
- Girish Kalra - Director
Mba Pharmaceuticals reported a net profit of ₹84,417 (net margin 0%) and EBITDA of ₹28.33 Lakh (EBITDA margin 1.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mba Pharmaceuticals is 5% over three years and -6% over five years. In the latest year (FY 2024) revenue fell 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mba Pharmaceuticals is 07AAJCM1075D1ZO, registered in Delhi.
The CIN (Corporate Identification Number) of Mba Pharmaceuticals is U51397DL2014PTC265441. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mba Pharmaceuticals has 6 court cases on record: 5 filed by the company and 1 filed against it.
Mba Pharmaceuticals was incorporated on 26 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Mba Pharmaceuticals by revenue are Shanpar Pharmachem Private Limited, Cornel Pharmaceuticals Private Limited, Acinta Pharmaceuticals Private Limited, Mannequin Pharmaceuticals Private Limited, Sal Corporation Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Girish Kalra was appointed as Director on 26 Feb 2014. Jitender Kumar was appointed as Director on 26 Feb 2014.